| Literature DB >> 31641175 |
Inês Paciência1,2,3, João Cavaleiro Rufo4,5,6, Diana Silva4, Carla Martins4, Francisca Mendes4, Tiago Rama4, Ana Rodolfo4, Joana Madureira5, Luís Delgado4, Eduardo de Oliveira Fernandes5, Patrícia Padrão6,7, Pedro Moreira6,7, Milton Severo6,8, Maria Fátima Pina9,10,11, João Paulo Teixeira6,12, Henrique Barros6,8, Lasse Ruokolainen13, Tari Haahtela14, André Moreira4,6,7.
Abstract
Children are in contact with local environments, which may affect respiratory symptoms and allergic sensitization. We aimed to assess the effect of the environment and the walkability surrounding schools on lung function, airway inflammation and autonomic nervous system activity. Data on 701 children from 20 primary schools were analysed. Lung function, airway inflammation and pH from exhaled breath condensate were measured. Pupillometry was performed to evaluate autonomic activity. Land use composition and walkability index were quantified within a 500 m buffer zone around schools. The proportion of effects explained by the school environment was measured by mixed-effect models. We found that green school areas tended to be associated with higher lung volumes (FVC, FEV1 and FEF25-75%) compared with built areas. FVC was significantly lower in-built than in green areas. After adjustment, the school environment explained 23%, 34% and 99.9% of the school effect on FVC, FEV1, and FEF25-75%, respectively. The walkability of school neighbourhoods was negatively associated with both pupil constriction amplitude and redilatation time, explaining -16% to 18% of parasympathetic and 8% to 29% of sympathetic activity. Our findings suggest that the environment surrounding schools has an effect on the lung function of its students. This effect may be partially mediated by the autonomic nervous system.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31641175 PMCID: PMC6805928 DOI: 10.1038/s41598-019-51659-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Multilevel model analysis of the association between individual and neighbouring environment and lung function, pH, exhaled NO and pupillometry parameters explained by school.
| Outcome | β (95% CI) | School | |||
|---|---|---|---|---|---|
| ICC | Variance | Explained variation* | |||
| PC1 | PC2 | ||||
|
| |||||
| Model 0 | 2.17 (−1.98; 6.33) | −5.13 (−9.36; −0.91) | — | — | — |
| Model 1 | — | — | 1.78% | 4.48 | Reference |
| Model 5a | 3.66 (−3.01; 10.3) | −1.33 (−7.87; 5.02) | 0.04% | 0.08 | 98.2% |
|
| |||||
| Model 0 | 2.78 (−1.07; 6.63) | −3.11 (−7.02; 0.81) | — | — | — |
| Model 1 | — | — | 2.13% | 4.53 | Reference |
| Model 5a | 1.54 (−4.58; 7.65) | 1.07 (−4.93; 7.07) | 0.40% | 0.16 | 96.5% |
|
| |||||
| Model 0 | 5.05 (−1.27; 11.4) | −0.50 (−6.94; 5.93) | — | — | — |
| Model 1 | — | — | 0.37% | 2.14 | Reference |
| Model 5a | −5.19 (−16.2; 5.77) | 4.86 (−5.89; 15.6) | 7.10E-7% | 3.71E-6 | >99.9% |
|
| |||||
| Model 0 | 0.02 (−0.20; 0.24) | −0.05 (−0.17; 0.17) | — | — | — |
| Model 1 | — | — | 2.04% | 4.33 | Reference |
| Model 5a | 0.12 (−0.53; 0.77) | −0.002 (−0.65; 0.64) | 9.32% | 0.09 | 97.8% |
|
| |||||
| Model 0 | 0.20 (−0.02; 0.41) | −0.14 (−0.35; 0.07) | — | — | — |
| Model 1 | — | — | 3.98% | 0.03 | Reference |
| Model 5b | −0.12 (−0.68; 0.44) | −0.37 (−0.93; 0.18) | 6.76% | 0.05 | −54.6% |
|
| |||||
| Model 0 | −0.09 (−0.32; 0.14) | −0.03 (−0.26; 0.19) | — | — | — |
| Model 1 | — | — | 20.3% | 0.158 | Reference |
| Model 5c | −0.12 (−0.84; 0.60) | 0.02 (−0.70; 0.75) | 22.1% | 0.178 | −12.5% |
|
| |||||
| Model 0 | −0.08 (−0.24; 0.08) | −0.10 (−0.26; 0.06) | — | — | — |
| Model 1 | — | — | 14.1% | 0.053 | Reference |
| Model 5c | −0.10 (−0.51; 0.31) | −0.07 (−0.48; 0.35) | 15.1% | 0.059 | −10.3% |
|
| |||||
| Model 0 | −0.11 (−0.29; 0.07) | 0.17 (−0.01; 0.35) | — | — | — |
| Model 1 | — | — | 15.7% | 0.075 | Reference |
| Model 5c | −0.05 (−0.56; 0.45) | 0.23 (−0.28; 0.74) | 16.7% | 0.081 | −8.24% |
|
| |||||
| Model 0 | −0.06 (−0.32; 0.19) | 0.26 (0.01; 0.51) | — | — | — |
| Model 1 | — | — | 12.1% | 0.122 | Reference |
| Model 5c | 0.03 (−0.61; 0.68) | 0.26 (−0.39; 0.91) | 12.7% | 0.118 | −6.12% |
|
| |||||
| Model 0 | −0.25 (−1.56; 1.04) | 1.17 (−0.12; 2.45) | — | — | — |
| Model 1 | — | — | 8.38% | 2.07 | Reference |
| Model 5c | −0.07 (−2.80; 2.65) | 1.50 (−1.26; 4.27) | 7.52% | 1.85 | 10.9% |
|
| |||||
| Model 0 | −0.02 (−0.10; 0.07) | 0.06 (−0.03; 0.14) | — | — | — |
| Model 1 | — | — | 8.57E-8% | 8.10E-11 | Reference |
| Model 5c | −0.02 (−0.13; 0.09) | 0.06 (−0.05; 0.17) | 7.82E-8% | 7.48E-11 | 7.60% |
|
| |||||
| Model 0 | 0.21 (0.01; 0.42) | −0.13 (−0.33; 0.06) | — | — | — |
| Model 1 | — | — | 4.53% | 0.023 | Reference |
| Model 5c | 0.31 (−5.07E-4; 0.63) | −0.10 (−0.42; 0.22) | 3.89% | 0.020 | 13.0% |
*corresponds to the proportion of between-schools variance that could be explained by exposure and individual characteristics; PC1: discontinuous dense urban fabric, discontinuous medium density urban land, green urban areas, and water bodies; PC2: construction sites, land without current use, and railways; 95% CI: 95% confidence interval; ICC: intra-class correlation coefficient; FVC: forced vital capacity; FEV1: forced expiratory volume in the first second of FVC; FEF25–75: forced expiratory flow in the middle portion of FVC; EBC: Exhaled breath condensate; ACV: Average constriction velocity; MCV: Maximum constriction velocity; ADV: Average dilation velocity; T75: the total time taken by the pupil to recover 75% of its initial resting diameter after it reached the peak of constriction.
Model 0 only included the PC1 and PC2 score; aModel 1 is null model, baseline model without any exposure variable; Model 5a is additionally adjusted for age, sex, asthma, WHO z-score for BMI and family history of asthma or allergy; Model 5b is additionally adjusted for age, sex, asthma, atopy, WHO z-score for BMI and family history of asthma or allergy; Model 5c is additionally adjusted for age, sex, asthma, and WHO z-score for BMI.
Multilevel model analysis of the association between individual and walkability and lung function, pH, exhaled NO and pupillometry parameters explained by school.
| Outcome | Walkabilityβ (95% CI) | School | ||
|---|---|---|---|---|
| ICC | Variance | Explained variation* | ||
|
| ||||
| Model 0 | −0.58 (−2.79; 1.63) | — | — | — |
| Model 1 | — | 1.78% | 4.48 | Reference |
| Model 5a | −2.62 (−6.00; 0.77) | 1.32E-6% | 2.51E-6 | >99.9% |
|
| ||||
| Model 0 | −1.02 (−3.07; 1.02) | — | — | — |
| Model 1 | — | 2.09% | 4.53 | Reference |
| Model 5a | −2.63 (−5.71; 0.46) | 4.47E-7% | 7.09E-7 | >99.9% |
|
| ||||
| Model 0 | −1.27 (−4.74; 1.98) | — | — | — |
| Model 1 | — | 0.37% | 2.14 | Reference |
| Model 5a | −0.72 (−6.33; 4.89) | 5.27E-7 | 2.77E-6 | >99.9% |
|
| ||||
| Model 0 | 0.09 (−0.03; 0.21) | — | — | — |
| Model 1 | — | 3.48% | 0.03 | Reference |
| Model 5a | −0.004 (−0.34; 0.33) | 8.52% | 0.08 | >−99.9% |
|
| ||||
| Model 0 | −0.05 (−0.17; 0.07) | — | — | — |
| Model 1 | — | 3.98% | 0.03 | Reference |
| Model 5b | −0.07 (−0.38; 0.23) | 8.07% | 0.06 | −90.6% |
|
| ||||
| Model 0 | −0.22 (−0.34; −0.09) | — | — | — |
| Model 1 | — | 20.4% | 0.158 | Reference |
| Model 5c | −0.18 (−0.54; 0.17) | 22.1% | 0.178 | −12.5% |
|
| ||||
| Model 0 | −0.04 (−0.13; 0.05) | — | — | — |
| Model 1 | — | 14.1% | 0.053 | Reference |
| Model 5c | −0.05 (−0.26; 0.16) | 15.1% | 0.059 | −10.3% |
|
| ||||
| Model 0 | −0.22 (−0.32; −0.12) | — | — | — |
| Model 1 | — | 14.7% | 0.070 | Reference |
| Model 5c | −0.21 (−0.46; 0.03) | 16.7% | 0.081 | −16.4% |
|
| ||||
| Model 0 | −0.31 (−0.45; −0.17) | — | — | — |
| Model 1 | — | 12.3% | 0.112 | Reference |
| Model 5c | −0.29 (−0.60; 0.02) | 10.1% | 0.091 | 18.0% |
|
| ||||
| Model 0 | −1.94 (−2.65; −1.23) | — | — | — |
| Model 1 | — | 8.38% | 2.073 | Reference |
| Model 5c | −1.62 (−2.87; −0.37) | 7.52% | 1.847 | 10.9% |
|
| ||||
| Model 0 | 0.01 (−0.04; 0.06) | — | — | — |
| Model 1 | — | 8.57E-8% | 8.10E-11 | Reference |
| Model 5c | 0.005 (−0.06; 0.07) | 7.82E-8% | 7.48E-11 | 7.60% |
|
| ||||
| Model 0 | −0.17 (−0.29; −0.06) | — | — | — |
| Model 1 | — | 4.53% | 0.023 | Reference |
| Model 5c | −0.19 (−0.36; −0.02) | 3.19% | 0.016 | 29.3% |
*corresponds to the proportion of between-schools variance that could be explained by exposure and individual characteristics; 95% CI: 95% confidence interval; ICC: intra-class correlation coefficient; FVC: forced vital capacity; FEV1: forced expiratory volume in the first second of FVC; FEF25–75: forced expiratory flow in the middle portion of FVC; EBC: Exhaled breath condensate; ACV: Average constriction velocity; MCV: Maximum constriction velocity; ADV: Average dilation velocity; T75: the total time taken by the pupil to recover 75% of its initial resting diameter after it reached the peak of constriction.
Model 0 only included the PC1 and PC2 score; a Model 1 is null model, baseline model without any exposure variable; Model 5a is additionally adjusted for age, sex, asthma, WHO z-score for BMI and family history of asthma or allergy; Model 5a is additionally adjusted for age, sex, asthma, atopy, WHO z-score for BMI and family history of asthma or allergy; Model 5c is additionally adjusted for age, sex, asthma, and WHO z-score for BMI.
Figure 1Environment-lung function interaction: a hypothesis focused on autonomic nervous system activity.
Figure 2Neighbourhood land use around the 20 evaluated primary schools in Porto. Each school was represented by a point and a circular buffer of 500 metres. For this assessment, we used the ArcGIS 10.4 Network Analyst tool (Environmental Systems Research Institute, ESRI, Redlands, CA, USA).
Figure 3Neighbourhood walkability index around each primary school. Each school, represented by a number and a circular buffer of 500 metres, was characterized according to tertiles of neighbourhood walkability. For this assessment, we used the ArcGIS 10.4 Network Analyst tool (Environmental Systems Research Institute, ESRI, Redlands, CA, USA).
Characteristics of the participants.
| Characteristics | Total n = 701 | Girls n = 357 | Boys n = 344 | |
|---|---|---|---|---|
| Age [years (mean ± SD)] | 9 ± 0.8 | 9 ± 0.8 | 9 ± 0.8 | 0.574 |
| Wheezing symptoms [n (%)] | 66 (9.4) | 34 (9.5) | 32 (9.3) | 0.920 |
| Cough symptoms [n (%)] | 82 (11.7) | 45 (12.6) | 37 (10.8) | 0.446 |
| Asthma [n (%)]** | 75 (10.7) | 47 (13.2) | 28 (8.1) | 0.037 |
| Rhinitis [n (%)] | 81 (13.0) | 36 (11.3) | 45 (14.8) | 0.233 |
| Current rhinitis [n (%)] | 69 (30.4) | 32 (26.8) | 37 (34.3) | 0.611 |
| Atopy [n (%)] | 245 (355) | 128 (36.4) | 117 (34.5) | 0.580 |
| BMI [n (%)] | 0.978 | |||
| Underweight | 33 (4.7) | 17 (4.8) | 16 (4.7) | |
| Normal weight | 478 (68.2) | 242 (67.8) | 236 (68.6) | |
| Overweight | 108 (15.4) | 57 (16.0) | 51 (14.8) | |
| Obese | 82 (11.7) | 41 (11.5) | 41 (11.9) | |
| EBC pH | 6.9 (0.9) | 6.8 (0.9) | 6.9 (0.9) | 0.105 |
| Exhaled NO (ppb) | 17.1 (20.1) | 14.6 (15.5) | 19.6 (23.7) | 0.010 |
| Lung function | ||||
| FVC (%) | 106.8 (15.7) | 113.4 (14.9) | 99.7 (13.2) | < 0.0001 |
| FEV1 (%) | 102.8 (14.6) | 109.3 (13.8) | 95.8 (11.8) | < 0.0001 |
| FEF25–75 (%) | 98.1 (24.3) | 98.6 (24.3) | 97.6 (24.2) | 0.486 |
| Pupillometry | ||||
| Baseline pupil diameter (mm) | 5.3 (0.9) | 5.2 (0.9) | 5.3 (0.9) | 0.137 |
| Final pupil diameter (mm) | 3.4 (0.6) | 3.4 (0.6) | 3.4 (0.6) | 0.745 |
| ACV (mm/s) | −3.9 0.7) | −3.9 (0.7) | −4.0 (0.7) | 0.096 |
| MCV (mm/s) | −5.2 (1.0) | −5.1 (1.0) | −5.4 (1.0) | 0.021 |
| Constriction amplitude (%) | 35.1 (4.8) | 34.5 (4.8) | 35.6 (4.7) | 0.017 |
| ADV (mm/s) | 1.1 (0.3) | 1.2 (0.3) | 1.1 (0.3) | 0.750 |
| T75 (s) | 1.7 (0.7) | 1.7 (0.7) | 1.8 (0.7) | 0.203 |
Data reported as median (interquartile range) unless otherwise stated. BMI: body mass index; FVC: forced vital capacity; FEV1: forced expiratory volume in the first second of FVC; FEF25–75: forced expiratory flow in the middle portion of FVC; EBC: Exhaled breath condensate; ACV: Average constriction velocity; MCV: Maximum constriction velocity; ADV: Average dilation velocity; T75: the total time taken by the pupil to recover 75 of its initial resting diameter after it reached the peak of constriction.